BioWorld

March 25, 2003

Elan, Ingenium Collaborate On Products For Pain Management

A collaboration announced by Elan Corp. plc and Ingenium Pharmaceuticals AG to develop therapeutics for pain management represents a strategic investment for both companies. (BioWorld Today) Read More

Zelos To Apply C$14M To Push Osteoporosis Product Into Clinic

Transgenic Rodents Fortified With Defensin Gene Kill Off Salmonella Bacteria; Wild Types Go Belly-Up

Celltech's Acquisition Of Stake In OGS Puts Pressure On CAT

Dermatology Meeting Brings Together Psoriasis Competitors

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Dec. 19, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 19, 2025.

Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

HIV research is close to a cure but far from ending the pandemic

BioWorld

Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...

Apollo’s APL-4098 shows potent antileukemic effects

BioWorld Science

Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.

Illustration of brain with electrical activity background

ABS-1230 controls seizures in KCNT1-driven severe epilepsy

BioWorld Science

Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...